Synthesis and antimicrobial activity evaluation of new 1,2,4-triazoles and 1,3,4-thiadiazoles bearing imidazo[2,1-b]thiazole moiety

被引:200
作者
Guzeldemirci, Nuray Ulusoy [1 ]
Kucukbasmaci, Oemer [2 ]
机构
[1] Istanbul Univ, Fac Pharm, Dept Pharmaceut Chem, Istanbul, Turkey
[2] Istanbul Univ, Cerrahpasa Fac Med, Dept Microbiol, Istanbul, Turkey
关键词
Imidazo[2,1-b]thiazole; 1,2,4-Triazole; 1,3,4-Thiadiazole; Antibacterial activity; Antifungal activity; Antimycobacterial activity; ANTIINFLAMMATORY ACTIVITIES; ANTIMYCOBACTERIAL ACTIVITY; CYTOTOXICITY EVALUATION; ANTICONVULSANT ACTIVITY; ANTIFUNGAL ACTIVITY; ANTICANCER ACTIVITY; ANALGESIC ACTIVITY; ACID-DERIVATIVES; ANTIBACTERIAL; TUBERCULOSIS;
D O I
10.1016/j.ejmech.2009.09.024
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of 4-alkyl/aryl-2,4-dihydro-5-((6-(4-bromophenyl)imidazo[2,1-b]thiazol-3-yl)methyl)-3H-1,2,4-triazole-3-thiones (3a-i) and 2-alkyl/arylamino-5-((6-(4-bromophenyl)imidazo[2,1-b]thiazol-3-yl) methyl)-1,3,4-thiadiazoles (4a-c) were synthesized starting from 6-(4-bromophenyl)imidazo [2,1-b]thiazole-3-acetic acid hydrazide. The newly synthesized compounds were characterized by IR, (1)H NMR, mass and elemental analysis. All compounds were tested for antibacterial and antifungal activities. The antimicrobial activities of the compounds were assessed by the microbroth dilution technique. The compounds were also evaluated for antituberculosis activity against Mycobacterium tuberculosis H(37)Rv (ATCC 27294). The preliminary results revealed that some of the compounds exhibited promising antimicrobial activities. (C) 2009 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:63 / 68
页数:6
相关论文
共 51 条
  • [1] Synthesis and antiviral evaluation of novel 5-(N-Arylaminomethyl-1,3,4-oxadiazol-2-yl)hydrazines and their sugars, 1,2,4-triazoles, tetrazolles and pyrazolyl derivatives
    Abdel-Aal, Mohammed T.
    El-Sayed, Waled A.
    El-Kosy, Salah M.
    El-Ashry, El Sayed H.
    [J]. ARCHIV DER PHARMAZIE, 2008, 341 (05) : 307 - 313
  • [2] Synthesis and anticonvulsant activity of new 2-substituted-5-[2-(2-fluorophenoxy)phenyl]-1,3,4-oxadiazoles and 1,2,4-triazoles
    Almasirad, A
    Tabatabai, SA
    Faizi, M
    Kebriaeezadeh, A
    Mehrabi, N
    Dalvandi, A
    Shafiee, A
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (24) : 6057 - 6059
  • [3] Synthesis and insecticidal activity of 1,2,4-triazole derivatives
    Chai, B
    Qian, XH
    Cao, S
    Liu, HD
    Song, GH
    [J]. ARKIVOC, 2003, : 141 - 145
  • [4] Clinical and Laboratory Standards Institute, 2005, M100S15 CLIN LAB S S
  • [5] Microplate Alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium
    Collins, LA
    Franzblau, SG
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (05) : 1004 - 1009
  • [6] Synthesis and antimicrobial activities of some new [1,2,4] triazolo[3,4-b][1,3,4]thiadiazoles and [1,2,4]triazolo[3,4-b][1,3,4]thiadiazines
    Demirbas, N
    Demirbas, A
    Karaoglu, SA
    Çelik, E
    [J]. ARKIVOC, 2005, : 75 - 91
  • [7] Synthesis and preliminary anticancer activity of new 1,4-dihydro-3-(3-hydroxy-2-naphthyl)-4-substituted-5H-1,2,4-triazoline-5-thiones
    Duran, A
    Dogan, HN
    Rollas, S
    [J]. FARMACO, 2002, 57 (07): : 559 - 564
  • [8] ERGENC N, 1995, FARMACO, V50, P189
  • [9] Synthesis and antimicrobial properties of new 4-(alkylidene/arylidene)-amino-5-(2-furanyl)-2,4-dihydro-3H-1,2,4-triazole-3-thiones and 6-aryl-3-(2-furanyl)-7H-1,2,4-triazolo[3,4-b][1,3,4]thiadiazines
    Ergenc, N
    Ulusoy, N
    Capan, G
    Sanis, GO
    Kiraz, M
    [J]. ARCHIV DER PHARMAZIE, 1996, 329 (8-9) : 427 - 430
  • [10] Farghaly AA, 2000, ARCH PHARM, V333, P53, DOI 10.1002/(SICI)1521-4184(200002)333:2/3<53::AID-ARDP53>3.0.CO